Cargando…
Coxsackievirus A11 is an immunostimulatory oncolytic virus that induces complete tumor regression in a human non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related mortality worldwide. Innovative treatment is required to improve overall survival rates for advanced NSCLC. Oncolytic virotherapy using enteroviruses has emerged as a promising anticancer strategy. To identify a novel, potent...
Autores principales: | Sakamoto, Akira, Inoue, Hiroyuki, Miyamoto, Shohei, Ito, Shun, Soda, Yasushi, Tani, Kenzaburo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10097657/ https://www.ncbi.nlm.nih.gov/pubmed/37046036 http://dx.doi.org/10.1038/s41598-023-33126-x |
Ejemplares similares
-
Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma
por: Okamura, Koji, et al.
Publicado: (2022) -
Extremely Low Organ Toxicity and Strong Antitumor Activity of miR-34-Regulated Oncolytic Coxsackievirus B3
por: Jia, Yang, et al.
Publicado: (2019) -
Immunostimulatory Gene Therapy Using Oncolytic Viruses as Vehicles
por: Loskog, Angelica
Publicado: (2015) -
Showing the Way: Oncolytic Adenoviruses as Chaperones of Immunostimulatory Adjuncts
por: Huang, Jing Li, et al.
Publicado: (2016) -
A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity
por: Nosaki, Kaname, et al.
Publicado: (2016)